tiprankstipranks

Brian Goff Insider Profile

4 Followers
Brian Goff, CEO, Director at Agios Pharma, holds 32.61K shares in Intellia Therapeutics (Ticker: NTLA), holds 184.51K shares in Agios Pharma (Ticker: AGIO), holds 0.00 shares in Alexion Pharmaceuticals (Ticker: ALXN).
tipranks
Brian Goff

Brian Goff
Agios Pharma (AGIO)
CEO, Director

Ranked #61,035 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-6.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
94.10%
5.90%
A breakdown of Brian Goff's holdings

Insider Roles

Agios Pharma
(AGIO)
CEO, Director
Intellia Therapeutics
(NTLA)
Director
Roles that Brian Goff holds in companies

Most Profitable Insider Trade

Stock:
Alexion Pharmaceuticals
(ALXN)
Rating:Informative Sell
Date:Jun 12, 2018 - Jun 12, 2019
Return:-2.60%
The most profitable trade made by Brian Goff

Brian Goff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agios Pharma
Apr 06, 2026
CEO, Director
Uninformative Buy
702.59K
$6.21M
Intellia Therapeutics
Jun 10, 2026
Director
Uninformative Buy
$389.03K
BXLT
Baxalta Incorporated
Jun 07, 2016
Uninformative Buy
$1.50M
ALXN
Alexion Pharmaceuticals
Jul 23, 2021
Uninformative Sell
$0.00
IDIX
Idenix Pharma
List of latest transactions for each holding click on a transaction to see Brian Goff's performance on stock

Brian Goff insider profile FAQ

What is the percentage of profitable transactions made by Brian Goff?
The percentage of profitable transactions made by Brian Goff is 0%.
    What is the average return per transaction made by Brian Goff?
    The average return per transaction made by Brian Goff is -6.60%.
      What stocks does Brian Goff hold?
      Brian Goff holds: AGIO, NTLA, BXLT, ALXN, IDIX stocks.
        What was Brian Goff’s latest transaction?
        Brian Goff latest transaction was an Uninformative Buy of ―.
          What was Brian Goff's most profitable transaction?
          Brian Goff’s most profitable transaction was an Informative Sell of ALXN stock on June 12, 2018. The return on the trade was -2.60%.
            What is Brian Goff's role in Agios Pharma?
            Brian Goff's role in Agios Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.